Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 11 studies | 41% ± 15% | |
basal cell | 9 studies | 26% ± 8% | |
ciliated cell | 9 studies | 28% ± 8% | |
respiratory goblet cell | 7 studies | 33% ± 16% | |
secretory cell | 7 studies | 30% ± 10% | |
goblet cell | 7 studies | 34% ± 7% | |
enterocyte | 6 studies | 29% ± 8% | |
plasmacytoid dendritic cell | 6 studies | 23% ± 4% | |
ionocyte | 5 studies | 55% ± 14% | |
myeloid cell | 5 studies | 18% ± 2% | |
squamous epithelial cell | 4 studies | 52% ± 16% | |
transit amplifying cell | 4 studies | 24% ± 6% | |
brush cell | 4 studies | 25% ± 5% | |
club cell | 3 studies | 34% ± 5% | |
conventional dendritic cell | 3 studies | 24% ± 6% | |
intestinal crypt stem cell | 3 studies | 24% ± 6% | |
macrophage | 3 studies | 18% ± 1% | |
type I pneumocyte | 3 studies | 23% ± 5% | |
dendritic cell | 3 studies | 30% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5693.76 | 328 / 328 | 97% | 308.85 | 173 / 178 |
thymus | 100% | 5369.84 | 652 / 653 | 96% | 207.29 | 579 / 605 |
lung | 94% | 3289.94 | 544 / 578 | 98% | 242.53 | 1127 / 1155 |
prostate | 89% | 4155.66 | 217 / 245 | 99% | 260.51 | 498 / 502 |
stomach | 76% | 4413.37 | 272 / 359 | 98% | 388.06 | 279 / 286 |
breast | 62% | 2362.58 | 285 / 459 | 95% | 151.66 | 1062 / 1118 |
kidney | 100% | 6591.87 | 89 / 89 | 54% | 111.69 | 487 / 901 |
intestine | 54% | 11319.13 | 520 / 966 | 98% | 484.73 | 519 / 527 |
bladder | 52% | 1868.76 | 11 / 21 | 95% | 335.30 | 480 / 504 |
esophagus | 39% | 5804.27 | 568 / 1445 | 97% | 245.07 | 178 / 183 |
tonsil | 0% | 0 | 0 / 0 | 100% | 224.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 197.59 | 1 / 1 |
ovary | 3% | 26.02 | 5 / 180 | 97% | 216.05 | 417 / 430 |
uterus | 7% | 271.58 | 12 / 170 | 86% | 248.98 | 395 / 459 |
spleen | 83% | 1472.76 | 199 / 241 | 0% | 0 | 0 / 0 |
skin | 72% | 5596.92 | 1305 / 1809 | 6% | 5.43 | 26 / 472 |
lymph node | 0% | 0 | 0 / 0 | 72% | 144.99 | 21 / 29 |
liver | 20% | 283.92 | 45 / 226 | 32% | 47.86 | 131 / 406 |
peripheral blood | 46% | 870.01 | 427 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 30% | 353.67 | 77 / 258 | 1% | 0.63 | 2 / 230 |
adipose | 21% | 440.28 | 255 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 9% | 150.09 | 114 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 12.48 | 22 / 2642 | 3% | 1.92 | 18 / 705 |
heart | 1% | 8.64 | 6 / 861 | 0% | 0 | 0 / 0 |
muscle | 0% | 2.93 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0006508 | Biological process | proteolysis |
GO_0001843 | Biological process | neural tube closure |
GO_0030163 | Biological process | protein catabolic process |
GO_0060672 | Biological process | epithelial cell morphogenesis involved in placental branching |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | ST14 |
Protein name | ST14 protein Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein) |
Synonyms | SNC19 PRSS14 TADG15 |
Description | FUNCTION: Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site . Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing . Proteolytically cleaves and therefore activates TMPRSS13 . . |
Accessions | ENST00000278742.6 Q8WVC1 Q9Y5Y6 |